FORTE Study: A Colorectal Cancer Prevention Trial

Want to join FORTE?
• Why Join the FORTE Study?
FORTE study is led by NRG Oncology and is a part of the National Clinical Trials Network (NCTN) program, which is sponsored by the National Cancer Institute (NCI).
FORTE is a colorectal cancer prevention study looking to determine how often participants who have had 1-2 small benign polyps removed during colonoscopy from their colon otherwise known as adenomatous polyps or adenomas should have repeat surveillance colonoscopies. The primary goal of FORTE is to compare the colorectal cancer rates between the two study groups (repeat colonoscopy at 5 and 10 years versus repeat colonoscopy at 10 years) to see if the rates are equivalent. If they are equivalent, then people in the future would likely be recommended to only undergo a 10-year exam and the 5-year exam may not be necessary. Participants will be asked to donate blood and stool samples and will be followed annually.
Learn more about the FORTE Study: www.nrgoncolog...
clinicaltrials...